DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+9.69%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.75B
AUM Growth
-$64.1M
(-2.3%)
Cap. Flow
-$747M
Cap. Flow
% of AUM
-27.18%
Top 10 Holdings %
Top 10 Hldgs %
32.38%
Holding
133
New
19
Increased
19
Reduced
27
Closed
26
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$65M |
| 2 |
XENT
Intersect ENT, Inc
XENT
|
$32.4M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$29.9M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$26.9M |
| 5 |
Acadia Healthcare
ACHC
|
$24.1M |
Top Sells
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$130M |
| 2 |
Tandem Diabetes Care
TNDM
|
$98.1M |
| 3 |
AET
Aetna Inc
AET
|
$42M |
| 4 |
CVS Health
CVS
|
$35.4M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$35.2M |
Sector Composition
| 1 | Healthcare | 69.76% |
| 2 | Financials | 1.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
26
DELISTED
Immunomedics Inc
IMMU
| $33.1M | 1.19% |
1,590,000
+465,200
| +41% | +$9.69M |
|
|
NVRO
27
DELISTED
NEVRO CORP.
NVRO
| $29.9M | 1.07% |
+525,040
| New | +$29.9M |
|
28
Galapagos
GLPG
$2.04B
| $29.2M | 1.05% |
260,064
+95,064
| +58% | +$10.7M |
|
29
Select Medical
SEM
$1.6B
| $28.1M | 1.01% |
2,832,256
-616,192
| -18% | -$6.11M |
|
30
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $27.1M | 0.97% |
1,061,956
-164,934
| -13% | -$4.21M |
|
31
Agios Pharmaceuticals
AGIO
$2.04B
| $26.9M | 0.96% |
348,200
-1,800
| -0.5% | -$139K |
|
32
Elevance Health
ELV
$69.6B
| $26M | 0.93% |
95,000
-96,000
| -50% | -$26.3M |
|
|
DFBHU
33
DELISTED
DFB Healthcare Acquisitions Corp. Unit
DFBHU
| $25.5M | 0.91% |
2,500,000
| – | – |
|
|
RETA
34
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $24M | 0.86% |
294,000
-315,554
| -52% | -$25.8M |
|
35
Vericel Corp
VCEL
$1.72B
| $22.9M | 0.82% |
+1,617,730
| New | +$22.9M |
|
36
Ascendis Pharma
ASND
$12.1B
| $22.7M | 0.81% |
320,000
-162,467
| -34% | -$11.5M |
|
37
Arvinas
ARVN
$559M
| $20.8M | 0.75% |
+1,233,734
| New | +$20.8M |
|
38
Regenxbio
RGNX
$469M
| $20.8M | 0.74% |
275,000
+150,000
| +120% | +$11.3M |
|
|
BOLD
39
DELISTED
Audentes Therapeutics, Inc
BOLD
| $19.6M | 0.7% |
493,901
-554,529
| -53% | -$22M |
|
40
Synlogic
SYBX
$17.1M
| $19.4M | 0.69% |
91,010
| – | – |
|
41
Fate Therapeutics
FATE
$110M
| $19.1M | 0.68% |
+1,173,617
| New | +$19.1M |
|
|
EPZM
42
DELISTED
Epizyme, Inc
EPZM
| $18.9M | 0.68% |
1,779,094
+140,094
| +9% | +$1.48M |
|
|
OXFD
43
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $17.6M | 0.63% |
1,087,359
-223,641
| -17% | -$3.63M |
|
|
DPLO
44
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $16.6M | 0.59% |
+853,687
| New | +$16.6M |
|
|
MOR
45
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $16M | 0.57% |
600,000
| – | – |
|
46
Zimmer Biomet
ZBH
$20.8B
| $15.9M | 0.57% |
124,630
| – | – |
|
47
Ardelyx
ARDX
$1.54B
| $15.2M | 0.54% |
3,491,922
| – | – |
|
|
SYRS
48
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $15.1M | 0.54% |
126,895
| – | – |
|
|
AIMT
49
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $15.1M | 0.54% |
553,000
-120,000
| -18% | -$3.27M |
|
|
GTHX
50
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $15M | 0.54% |
287,000
| – | – |
|